What the Options Market Tells Us About AbbVie
What the Options Market Tells Us About AbbVie
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ABBV, it often means somebody knows something is about to happen.Investors with a lot of money to spend have taken a bullish stance on AbbVie (NYSE:ABBV).
有大量资金可以花的投资者对艾伯维（纽约证券交易所代码：ABBV）采取了看涨立场。
And retail traders should know.
零售交易者应该知道。
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
今天，当我们在本辛加追踪的公开期权历史记录中出现头寸时，我们注意到了这一点。
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ABBV, it often means somebody knows something is about to happen.
无论这些是机构还是仅仅是富人，我们都不知道。但是，当ABBV发生这么大的事情时，通常意味着有人知道某件事即将发生。
Today, Benzinga's options scanner spotted 13 options trades for AbbVie.
今天，本辛加的期权扫描仪发现了艾伯维的13笔期权交易。
This isn't normal.
这不正常。
The overall sentiment of these big-money traders is split between 46% bullish and 46%, bearish.
这些大资金交易者的整体情绪在46％的看涨和46％的看跌之间。
Out of all of the options we uncovered, there was 1 put, for a total amount of $33,000, and 12, calls, for a total amount of $817,396.
在我们发现的所有期权中，有1份看跌期权，总额为33,000美元，还有12份看涨期权，总额为817,396美元。
Expected Price Movements
预期的价格走势
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $155.0 to $200.0 for AbbVie over the last 3 months.
考虑到这些合约的交易量和未平仓合约，在过去的3个月中，鲸鱼似乎一直将AbbVie的价格定在155.0美元至200.0美元之间。
Volume & Open Interest Development
交易量和未平仓合约的发展
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in AbbVie's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to AbbVie's substantial trades, within a strike price spectrum from $155.0 to $200.0 over the preceding 30 days.
评估交易量和未平仓合约是期权交易的战略步骤。这些指标揭示了艾伯维在指定行使价下期权的流动性和投资者对艾伯维期权的兴趣。即将发布的数据可视化了与艾伯维的大量交易相关的看涨期权和看跌期权的交易量和未平仓合约的波动，在过去30天内，行使价范围从155.0美元到200.0美元不等。
AbbVie Option Activity Analysis: Last 30 Days
AbbVie 期权活动分析：过去 30 天
Largest Options Trades Observed:
观察到的最大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | CALL | TRADE | BEARISH | 10/18/24 | $16.9 | $16.85 | $16.85 | $180.00 | $337.0K | 676 | 200 |
| ABBV | CALL | SWEEP | NEUTRAL | 10/18/24 | $3.3 | $3.25 | $3.25 | $200.00 | $109.1K | 2.4K | 520 |
| ABBV | CALL | SWEEP | BULLISH | 09/20/24 | $21.9 | $20.75 | $21.95 | $175.00 | $52.6K | 2.9K | 111 |
| ABBV | CALL | SWEEP | BEARISH | 10/18/24 | $21.95 | $21.6 | $21.72 | $175.00 | $52.1K | 287 | 0 |
| ABBV | CALL | TRADE | BULLISH | 11/15/24 | $15.1 | $15.05 | $15.1 | $185.00 | $37.7K | 3.1K | 88 |
| 符号 | 看跌/看涨 | 交易类型 | 情绪 | Exp。日期 | 问 | 出价 | 价格 | 行使价 | 总交易价格 | 未平仓合约 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABBV | 打电话 | 贸易 | 粗鲁的 | 10/18/24 | 16.9 美元 | 16.85 美元 | 16.85 美元 | 180.00 美元 | 337.0 万美元 | 676 | 200 |
| ABBV | 打电话 | 扫 | 中立 | 10/18/24 | 3.3 美元 | 3.25 | 3.25 | 200.00 美元 | 109.1 万美元 | 2.4K | 520 |
| ABBV | 打电话 | 扫 | 看涨 | 09/20/24 | 21.9 美元 | 20.75 美元 | 21.95 美元 | 175.00 美元 | 52.6 万美元 | 2.9K | 111 |
| ABBV | 打电话 | 扫 | 粗鲁的 | 10/18/24 | 21.95 美元 | 21.6 美元 | 21.72 美元 | 175.00 美元 | 52.1 万美元 | 287 | 0 |
| ABBV | 打电话 | 贸易 | 看涨 | 11/15/24 | 15.1 美元 | 15.05 美元 | 15.1 美元 | 185.00 美元 | 37.7 万美元 | 3.1K | 88 |
About AbbVie
关于 AbbVie
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
艾伯维是一家制药公司，在免疫学（与Humira、Skyrizi和Rinvoq合作）和肿瘤学（与Imbruvica和Venclexta合作）方面有着丰富的经验。该公司于2013年初从雅培分拆出来。2020年对Allergan的收购增加了几种美容领域的新产品和药物（包括肉毒杆菌毒素）。
Present Market Standing of AbbVie
艾伯维目前的市场地位
- Currently trading with a volume of 1,562,326, the ABBV's price is down by -1.93%, now at $195.5.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 44 days.
- ABBV目前的交易量为1,562,326美元，其价格下跌了-1.93％，目前为195.5美元。
- RSI读数表明，该股目前可能接近超买。
- 预计财报将在44天后发布。
Professional Analyst Ratings for AbbVie
AbbVie的专业分析师评级
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $209.0.
在过去的一个月中，1位行业分析师分享了他们对该股的见解，提出平均目标价为209.0美元。
- An analyst from Piper Sandler has decided to maintain their Overweight rating on AbbVie, which currently sits at a price target of $209.
- 派珀·桑德勒的一位分析师已决定维持对艾伯维的增持评级，目前的目标股价为209美元。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for AbbVie with Benzinga Pro for real-time alerts.
交易期权涉及更大的风险，但也提供了更高利润的潜力。精明的交易者通过持续的教育、战略贸易调整、利用各种指标以及随时关注市场动态来降低这些风险。使用Benzinga Pro获取实时提醒，随时了解AbbVie的最新期权交易。
